60 Degrees Pharmaceuticals, Inc.

SXTP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$7,956-$3,766-$6,178-$4,260
Dep. & Amort.$64$100$79$72
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,609$0$0$0
Change in WC$193$405$3,306$2,896
Other Non-Cash-$1,558-$1,283$1,783$643
Operating Cash Flow-$5,648-$4,543-$1,010-$649
Investing Activities
PP&E Inv.-$104-$58-$60-$3
Net Acquisitions$0$0$0$0
Inv. Purchases-$1,708$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$77-$58$0-$32
Investing Cash Flow-$1,889-$116-$60-$35
Financing Activities
Debt Repay.$0-$961$1,105$611
Stock Issued$7,043$6,454$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$11$981$117$0
Financing Cash Flow$7,054$6,475$1,222$611
Forex Effect$0$62-$2-$3
Net Chg. in Cash-$483$1,878$149-$76
Supplemental Information
Beg. Cash$2,142$265$115$192
End Cash$1,659$2,142$265$115
Free Cash Flow-$5,829-$4,659-$1,070-$684
60 Degrees Pharmaceuticals, Inc. (SXTP) Financial Statements & Key Stats | AlphaPilot